Medtronic Announces FDA Approval of New Portfolio Of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-DefibrillatorsMay 6, 2013 10:18 am | by Medtronic | News | Comments
Medtronic, Inc. has announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva® portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera® portfolio of implantable cardioverter-defibrillators (ICD).
AATS Report: Prospective Randomized On-X Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced ComplicationsMay 6, 2013 9:00 am | by The Associated Press | News | Comments
MINNEAPOLIS--(BUSINESS WIRE)--May 6, 2013--On-X ® Life Technologies, Inc. (On-X LTI) announced today that interim results for the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) are being presented at the American Association for Thoracic Surgery Annual (AATS) meeting by John...
AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core LabMay 6, 2013 9:00 am | by PR Newswire | News | Comments
BOSTON, May 6, 2013 /PRNewswire/ -- AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance...
Hansen Medical to Exhibit Magellan Robotic System at 8th Annual European Symposium of Vascular Biomaterials in FranceMay 6, 2013 8:03 am | by The Associated Press | News | Comments
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan Robotic System at the 8th Annual European Symposium of Vascular Biomaterials (ESVB) from Friday, May 10th to Monday, May 13th at the Strasbourg Hilton in...
HUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the...
Prompt use of an automated external defibrillator, or AED, can greatly increase the survival rates of people who suffer a cardiac arrest. And MIE Professor Tim Chan, working with Dr. Laurie Morrison at St. Michael's Hospital, has developed a formula to determine where best to place these costly but life-saving devices.
St. Jude Medical, a global medical device company, today announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) and Quartet lead to assess pacing in multiple locations in the heart.
Manny Villafaña, Chairman and CEO of Kips Bay Medical announced that on April 30, 2013, the Mayo Clinic performed its first implant of an eSVS Mesh at its Rochester, Minnesota facility. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. FDA in a number of preeminent cardiac surgery centers in both Europe and the United States.
Miniaturization of medical devices is dependent upon the reliability of their assembled components, which is crucial for proper functioning devices. Miniaturization creates material challenges—especially in electronic medical device applications such as implantable cardiac devices.
Corindus Vascular Robotics, a leading developer of precision vascular robotics, has announced that the Journal of American College of Cardiology published the results from its CorPath PRECISE study in the April 2013 issue. Results of the trial demonstrate the CorPath System is safe and feasible for patients, with significantly lower harmful radiation exposure to the operator.
CLEVELAND, Ohio, May 1, 2013 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training, is proud to announce the release of various training modules for the ANGIO Mentor™ endovascular simulator.
PLC Systems Inc. (OTCQB: PLCSF), a company focused on innovative medical device technologies, today announced it has been granted its first patent for RenalGuard® by the European Patent Office (EU Patent Number 2010268). This patent covers the core RenalGuard device and its redundant...
The newly reformatted MD&M East four day conference running alongside the tradeshow, covers everything you need to know from concept development to supplier management, giving you the essential updates to successfully management every step in the product development efficiently and cost effectively.
Pre-Clinical Study and Initial Clinical Experience Highlight Potential Benefits of Hansen Medical's Robotic Technology in Treating Carotid ArteriesApril 30, 2013 4:03 pm | by The Associated Press | News | Comments
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the results from a recently published pre-clinical study describing potential benefits of Hansen Medical's robotic technology for the treatment of carotid arteries. The study results appeared in...
St. Jude Medical, a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing options to deliver higher success rates, as evidenced by robust clinical data.
Teleflex Incorporated, has announced the first insertion of the new ARROW JACC Catheter with Chlorag + ard Technology. The ARROW JACC Catheter with Chlorag + ard Technology is a long-term, small bore antimicrobial and antithrombogenic catheter that gives clinicians a single, less-invasive option for critically ill patients for the duration of their therapy.
Medtronic Reports Initial Implants of Novel Stent Graft for Aortic Aneurysms Involving Branch VesselApril 29, 2013 4:32 pm | News | Comments
Vascular specialists at Carolinas HealthCare System in Charlotte, N.C., and the Cleveland Clinic in Ohio recently performed the initial implants of a novel stent graft system from Medtronic as part of a U.S. Food and Drug Administration initiative designed to encourage more early-stage clinical research on new medical devices in the United States.
Hansen Medical to Highlight Sensei X Robotic Catheter System and New Artisan Extend Control Catheter at Heart Rhythm Society Annual MeetingApril 29, 2013 4:03 pm | by The Associated Press | News | Comments
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will showcase its Sensei® X Robotic Catheter System with the new Artisan Extend® Catheter at the Heart Rhythm Society's (HRS) 34th Annual Scientific Sessions from May 8-11, 2013 in Denver,...
Going Under the Knife—Millions of Americans will have surgery this year. Whether it’s the result of an emergency, an exploratory procedure, or even elective, some surgical procedures are more common depending on your age. An infographic by the team at Top Surgeries Graphic - CompHealth.
Results from WEARIT-II Registry of Wearable Cardioverter Defibrillator Usage to Be Presented at Heart Rhythm 2013April 29, 2013 10:15 am | by The Associated Press | News | Comments
CHELMSFORD, Mass.--(BUSINESS WIRE)--Apr 29, 2013--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that results from the Prospective Registry and Follow-Up of Patients Using the Wearable Defibrillator (WEARIT-II) will be presented in a...
Sorin Group Receives Conditional FDA Approval to Conduct IDE Clinical Trial for Perceval (TM) S Sutureless Aortic Valve in the United StatesApril 29, 2013 10:00 am | by The Associated Press | News | Comments
MILAN, Italy--(BUSINESS WIRE)--Apr 29, 2013--Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today it has received U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption...
athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, in partnership with MIT's H@cking Medicine, invites the health care, technology and scientific communities to participate in a Hack-a-Thon on May 4 and 5 at athenahealth's headquarters in Watertown, Mass.
LIMERICK, Pa.--(BUSINESS WIRE)--Apr 29, 2013--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces that its ARROW ® VPS G4 ™ Device has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The ARROW...
Regular exercise has been proven to reduce the chance of developing liver cancer in a world-first mice study that carries hope for patients at risk from hepatocellular carcinoma (HCC). The research announced at the International Liver Congress™ 2013 involved two groups of mice fed a control diet and a high fat diet then divided into separate exercise and sedentary groups.
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that as a result of its continued growth it purchased a 124,500-square-foot building in San Jose, California, an area ranked as the country’s busiest advanced manufacturing corridor.